| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259045c6eba6e2c5d338b84e0a88b571 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2006-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_495d200687b4833bc89640a0d3ce757b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_069a149d1f1614b7cd56d4b71f25bb5a |
| publicationDate |
2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080043162-A |
| titleOfInvention |
Composition for regulating degradation of HIF1-α using the WDPP1 gene |
| abstract |
The present invention relates to a method for treating cancer, rheumatoid arthritis, psoriasis or diabetic retinopathy by regulating HIF1-α (Hypoxia-inducible factor 1-α), and more specifically, VDUP1 (Vitamin D3 upregulating protein 1) protein. Or it relates to a method for inhibiting the disease by using a gene encoding the VDUP1 or a substance encoding the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101522965-B1 |
| priorityDate |
2006-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |